Blood-based biomarker tests the new frontier for Alzheimer’s diagnosis: GlobalData
- Posted on November 6, 2024
- By Financial Express
- 3 Views
Blood-based biomarker tests the new frontier for Alzheimer’s diagnosis: GlobalData
GlobalData reports that at least five pipeline devices are now in the regulatory approval process across the US and Europe, yet ethical and regulatory challenges persist.
